Skip to main content
Erschienen in: Intensive Care Medicine 10/2004

01.10.2004 | Original

Role of 5-lipoxygenase in the multiple organ failure induced by zymosan

verfasst von: Salvatore Cuzzocrea, Antonietta Rossi, Ivana Serraino, Rosanna Di Paola, Laura Dugo, Tiziana Genovese, Domenico Britti, Giuseppe Sciarra, Angelina De Sarro, Achille P. Caputi, Lidia Sautebin

Erschienen in: Intensive Care Medicine | Ausgabe 10/2004

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study investigated the role of 5-lipoxygenase in the pathogenesis of multiple organ failure (MOF) induced by zymosan.

Design

Male mice with a targeted disruption of the 5-lipoxygenase gene (5-LOKO) and littermate wild-type (WT) controls (5-LOWT) were used to evaluate the role of 5-lipoxygenase (5-LO) in the pathogenesis of MOF.

Setting

University research laboratory.

Interventions and measurements

MOF was induced by peritoneal injection of zymosan (500 mg/kg i.p. as a suspension in saline) in 5-LOWT and in 5-LOKO mice. MOF was assessed 18 h after administration of zymosan and monitored for 12 days (for loss of body weight and mortality).

Results

A severe inflammatory process induced by zymosan administration in WT mice coincided with the damage of lung and small intestine, as assessed by histological examination. Myeloperoxidase activity indicative of neutrophil infiltration and lipid peroxidation were significantly increased in zymosan-treated WT mice. Zymosan in the WT mice also induced a significant increase in the plasma level of nitrite/nitrate. Immunohistochemical examination demonstrated a marked increase in the immunoreactivity to ICAM-1 and P-selectin in the lung and intestine of zymosan-treated WT mice. In contrast, the degree of (a) peritoneal inflammation and tissue injury, (b) upregulation/expression of P-selectin and ICAM-1, and (c) neutrophil infiltration were markedly reduced in intestine and lung tissue obtained from zymosan-treated 5-LO deficient mice. Zymosan-treated 5-LOKO showed also a significantly decreased mortality.

Conclusions

These findings clearly demonstrate that 5-LO exerts a role in zymosan-induced nonseptic shock.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874PubMed American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874PubMed
2.
Zurück zum Zitat Baue AE, Durham R, Faist E (1998) Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 10:79–89PubMed Baue AE, Durham R, Faist E (1998) Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 10:79–89PubMed
3.
Zurück zum Zitat Marshall JC (2001) Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29:S99–S106CrossRefPubMed Marshall JC (2001) Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29:S99–S106CrossRefPubMed
4.
Zurück zum Zitat Deitch EA (2000) Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care 7:92–98 Deitch EA (2000) Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care 7:92–98
5.
Zurück zum Zitat Volman TJ, Goris RJ, van der Jagt M, van de Loo FA, Hendriks T (2002) Organ damage in zymosan-induced multiple organ dysfunction syndrome in mice is not mediated by inducible nitric oxide synthase. Crit Care Med 30:1553–1559CrossRefPubMed Volman TJ, Goris RJ, van der Jagt M, van de Loo FA, Hendriks T (2002) Organ damage in zymosan-induced multiple organ dysfunction syndrome in mice is not mediated by inducible nitric oxide synthase. Crit Care Med 30:1553–1559CrossRefPubMed
6.
Zurück zum Zitat Van Bebber IPT, Boekholz KF, Goris RJA, Schillings PHM, Binges HP, Bahrami S, Redl H, Schlag G (1989) Neutrophil function and lipid peroxidation in rat model of multiple organ failure. J Surg Res 47:471–475CrossRefPubMed Van Bebber IPT, Boekholz KF, Goris RJA, Schillings PHM, Binges HP, Bahrami S, Redl H, Schlag G (1989) Neutrophil function and lipid peroxidation in rat model of multiple organ failure. J Surg Res 47:471–475CrossRefPubMed
7.
Zurück zum Zitat Petit F, Bagby GJ, Lang CH (1996) Tumour necrosis factor mediates zymosan induced increase in glucose flux and insulin resistance. Am J Physiol 268:E219–E228 Petit F, Bagby GJ, Lang CH (1996) Tumour necrosis factor mediates zymosan induced increase in glucose flux and insulin resistance. Am J Physiol 268:E219–E228
8.
Zurück zum Zitat Deitch EA, Ma L, Berg RD, Specian RD (1990) Protein malnutrition predisposes to inflammatory-induced gut-origin septic states. Ann Surg 221:560–568 Deitch EA, Ma L, Berg RD, Specian RD (1990) Protein malnutrition predisposes to inflammatory-induced gut-origin septic states. Ann Surg 221:560–568
9.
Zurück zum Zitat Goris RJA, Van Bebber IPT, Mollen RMH, Koopman JP (1991) Dose selective decontamination of the gastrointestinal tract prevent multiple organ failure? Arch Surg 126:561–565PubMed Goris RJA, Van Bebber IPT, Mollen RMH, Koopman JP (1991) Dose selective decontamination of the gastrointestinal tract prevent multiple organ failure? Arch Surg 126:561–565PubMed
10.
Zurück zum Zitat Mainous MR, Ertel W, Chaudry IH, Deitch EA (1995) The gut: a cytokine-generating organ in systemic inflammation? Shock 4:193–199PubMed Mainous MR, Ertel W, Chaudry IH, Deitch EA (1995) The gut: a cytokine-generating organ in systemic inflammation? Shock 4:193–199PubMed
11.
Zurück zum Zitat Cuzzocrea S, De Sarro GB, Costantino G, Mazzon E, Laurà R, Ciriaco E, De Sarro A, Caputi AP (1999) Role of interleukine-6 in a non-septic shock model induced by zymosan. Eur Cytokine Netw 10:191–203PubMed Cuzzocrea S, De Sarro GB, Costantino G, Mazzon E, Laurà R, Ciriaco E, De Sarro A, Caputi AP (1999) Role of interleukine-6 in a non-septic shock model induced by zymosan. Eur Cytokine Netw 10:191–203PubMed
12.
Zurück zum Zitat Cuzzocrea S, Mazzon E, Dugo L, Barbera A, Centorrino T, Ciccolo A, Fonti MT, Caputi AP (2001) Inducible nitric oxide synthase knock out mice exhibit a resistance to multiple organ failure induced by zymosan. Shock 16:51–58 Cuzzocrea S, Mazzon E, Dugo L, Barbera A, Centorrino T, Ciccolo A, Fonti MT, Caputi AP (2001) Inducible nitric oxide synthase knock out mice exhibit a resistance to multiple organ failure induced by zymosan. Shock 16:51–58
13.
Zurück zum Zitat Devchand PR, Arita M, Hong S, Bannenberg G, Moussignac RL, Gronert K, Serhan CN (2003) Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J 17:652–659CrossRefPubMed Devchand PR, Arita M, Hong S, Bannenberg G, Moussignac RL, Gronert K, Serhan CN (2003) Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J 17:652–659CrossRefPubMed
14.
Zurück zum Zitat Kolaczkowska E, Shahzidi S, Seljelid R, van Rooijen N, Plytycz B (2002) Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation 26:61–71CrossRefPubMed Kolaczkowska E, Shahzidi S, Seljelid R, van Rooijen N, Plytycz B (2002) Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation 26:61–71CrossRefPubMed
15.
Zurück zum Zitat Haribabu B, Verghese MW, Steeber DA, Sellars DD, Bock CB, Snyderman R (2000) Targeted disruption of the leukotriene B (4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J Exp Med 192:433–438CrossRefPubMed Haribabu B, Verghese MW, Steeber DA, Sellars DD, Bock CB, Snyderman R (2000) Targeted disruption of the leukotriene B (4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J Exp Med 192:433–438CrossRefPubMed
16.
Zurück zum Zitat Dahlen SE (1998) Lipid mediator pathways in the lung: leukotrienes as a new target for the treatment of asthma. Clin Exp Allergy 5:141–146CrossRef Dahlen SE (1998) Lipid mediator pathways in the lung: leukotrienes as a new target for the treatment of asthma. Clin Exp Allergy 5:141–146CrossRef
17.
Zurück zum Zitat Goulet JL, Byrum RS, Key ML, Nguyen M, Wagoner VA, Koller BH (2000) Genetic factors determine the contribution of leukotrienes to acute inflammatory responses. J Immunol 164:4899–4907PubMed Goulet JL, Byrum RS, Key ML, Nguyen M, Wagoner VA, Koller BH (2000) Genetic factors determine the contribution of leukotrienes to acute inflammatory responses. J Immunol 164:4899–4907PubMed
18.
Zurück zum Zitat Byrum RS, Goulet JL, Snouwaert JN, Griffiths RJ, Koller BH (1999) Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. J Immunol 163:6810–5819PubMed Byrum RS, Goulet JL, Snouwaert JN, Griffiths RJ, Koller BH (1999) Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. J Immunol 163:6810–5819PubMed
19.
Zurück zum Zitat Gardinali M, Borrelli E, Chiara O, Lundberg C, Padalino P, Conciato L, Cafaro C, Lazzi S, Luzi P, Giomarelli PP, Agostoni A (2000) Inhibition of CD11-CD18 complex prevents acute lung injury and reduces mortality after peritonitis in rabbits. Am J Respir Crit Care Med 161:1022–1029PubMed Gardinali M, Borrelli E, Chiara O, Lundberg C, Padalino P, Conciato L, Cafaro C, Lazzi S, Luzi P, Giomarelli PP, Agostoni A (2000) Inhibition of CD11-CD18 complex prevents acute lung injury and reduces mortality after peritonitis in rabbits. Am J Respir Crit Care Med 161:1022–1029PubMed
20.
Zurück zum Zitat Heller AR, Fiedler F, Braun P, Stehr SN, Bodeker H, Koch T (2003) Clusterin protects the lung from leukocyte-induced injury. Shock 20:166–170CrossRefPubMed Heller AR, Fiedler F, Braun P, Stehr SN, Bodeker H, Koch T (2003) Clusterin protects the lung from leukocyte-induced injury. Shock 20:166–170CrossRefPubMed
21.
Zurück zum Zitat Swartz DE, Seely AJ, Ferri L, Giannias B, Christou NV (2000) Decreased systemic polymorphonuclear neutrophil (PMN) rolling without increased PMN adhesion in peritonitis at remote sites. Arch Surg 135:959–966CrossRefPubMed Swartz DE, Seely AJ, Ferri L, Giannias B, Christou NV (2000) Decreased systemic polymorphonuclear neutrophil (PMN) rolling without increased PMN adhesion in peritonitis at remote sites. Arch Surg 135:959–966CrossRefPubMed
22.
Zurück zum Zitat Tsujimoto H, Ono S, Mochizuki H, Aosasa S, Majima T, Ueno C, Matsumoto A (2002) Role of macrophage inflammatory protein 2 in acute lung injury in murine peritonitis. J Surg Res 103:61–67CrossRefPubMed Tsujimoto H, Ono S, Mochizuki H, Aosasa S, Majima T, Ueno C, Matsumoto A (2002) Role of macrophage inflammatory protein 2 in acute lung injury in murine peritonitis. J Surg Res 103:61–67CrossRefPubMed
23.
Zurück zum Zitat Grutkoski PS, Graeber CT, Ayala A, Simms HH (2002) Paracrine suppression of apoptosis by cytokine-stimulated neutrophils involves divergent regulation of NF-kappaB, Bcl-X (L), and Bak. Shock 2002 17:47–54 Grutkoski PS, Graeber CT, Ayala A, Simms HH (2002) Paracrine suppression of apoptosis by cytokine-stimulated neutrophils involves divergent regulation of NF-kappaB, Bcl-X (L), and Bak. Shock 2002 17:47–54
24.
Zurück zum Zitat Cuzzocrea S, Rossi A, Serraino I, Mazzon E, Di Paola R, Dugo L, Genovese T, Calabro B, Caputi AP, Sautebin L (2003) 5-Lipoxygenase knockout mice exhibit a resistance to pleurisy and lung injury caused by carrageenan. J Leukoc Biol 73:739–746CrossRefPubMed Cuzzocrea S, Rossi A, Serraino I, Mazzon E, Di Paola R, Dugo L, Genovese T, Calabro B, Caputi AP, Sautebin L (2003) 5-Lipoxygenase knockout mice exhibit a resistance to pleurisy and lung injury caused by carrageenan. J Leukoc Biol 73:739–746CrossRefPubMed
25.
Zurück zum Zitat Baue AE (1993) The multiple organ or system failure syndrome. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis, and organ failure. Springer, Berlin Heidelberg New York, pp 1004–1018 Baue AE (1993) The multiple organ or system failure syndrome. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis, and organ failure. Springer, Berlin Heidelberg New York, pp 1004–1018
26.
Zurück zum Zitat Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMed Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358PubMed
27.
Zurück zum Zitat Cuzzocrea S, Filippelli A, Zingarelli B (1997) Role of nitric oxide in a non-septic shock model induced by zymosan in the rat. Shock 351–358 Cuzzocrea S, Filippelli A, Zingarelli B (1997) Role of nitric oxide in a non-septic shock model induced by zymosan in the rat. Shock 351–358
28.
Zurück zum Zitat Demling R, Nayak U, Ikegami K (1994) Comparison between lung and liver peroxidation and mortality after zymosan peritonitis in the rats. Shock 2:222–227PubMed Demling R, Nayak U, Ikegami K (1994) Comparison between lung and liver peroxidation and mortality after zymosan peritonitis in the rats. Shock 2:222–227PubMed
29.
Zurück zum Zitat Vliet A van der, van der Poel KI, Bast A (1992) Intestinal smooth muscle dysfunction after intraperitoneal injection of zymosan in the rat: are oxygen radicals involved? Gut 33:336–341PubMed Vliet A van der, van der Poel KI, Bast A (1992) Intestinal smooth muscle dysfunction after intraperitoneal injection of zymosan in the rat: are oxygen radicals involved? Gut 33:336–341PubMed
30.
Zurück zum Zitat Cuzzocrea S, Riley DP, Caputi AP, Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53:135–159PubMed Cuzzocrea S, Riley DP, Caputi AP, Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53:135–159PubMed
31.
Zurück zum Zitat Cuzzocrea S, Rossi A, Serraino I, Di Paola R, Dugo L, Genovese T, Caputi AP, Sautebin L (2003) 5-Lipoxygenase knock out mice exhibit a resistance to splanchnic artery occlusion (SAO) shock. Shock 20:230–236CrossRefPubMed Cuzzocrea S, Rossi A, Serraino I, Di Paola R, Dugo L, Genovese T, Caputi AP, Sautebin L (2003) 5-Lipoxygenase knock out mice exhibit a resistance to splanchnic artery occlusion (SAO) shock. Shock 20:230–236CrossRefPubMed
32.
Zurück zum Zitat Cuzzocrea S, Rossi A, Serraino I, Di Paola R, Dugo L, Genovese T, Britti D, Sciarra G, De Sarro A, Caputi AP, Sautebin L (2003) 5-lipoxygenase knock out mice exhibit a resistance to the acute pancreatitis induced by cerulein. Immunology 110:120–130CrossRefPubMed Cuzzocrea S, Rossi A, Serraino I, Di Paola R, Dugo L, Genovese T, Britti D, Sciarra G, De Sarro A, Caputi AP, Sautebin L (2003) 5-lipoxygenase knock out mice exhibit a resistance to the acute pancreatitis induced by cerulein. Immunology 110:120–130CrossRefPubMed
33.
Zurück zum Zitat Coffey MJ, Phare SM, Peters-Golden M (2002) Interaction between nitric oxide, reactive oxygen intermediates, and peroxynitrite in the regulation of 5-lipoxygenase metabolism. Biochim Biophys Acta 1584:81–90CrossRefPubMed Coffey MJ, Phare SM, Peters-Golden M (2002) Interaction between nitric oxide, reactive oxygen intermediates, and peroxynitrite in the regulation of 5-lipoxygenase metabolism. Biochim Biophys Acta 1584:81–90CrossRefPubMed
34.
Zurück zum Zitat Vicente AM, Guillen MI, Alcaraz MJ (2001) Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages. Br J Pharmacol 133:920–926PubMed Vicente AM, Guillen MI, Alcaraz MJ (2001) Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages. Br J Pharmacol 133:920–926PubMed
35.
Zurück zum Zitat Fermor B, Haribabu B, Weinberg JB, Pisetsky DS, Guilak F (2001) Mechanical stress and nitric oxide influence leukotriene production in cartilage. Biochem Biophys Res Commun 285:806–810CrossRefPubMed Fermor B, Haribabu B, Weinberg JB, Pisetsky DS, Guilak F (2001) Mechanical stress and nitric oxide influence leukotriene production in cartilage. Biochem Biophys Res Commun 285:806–810CrossRefPubMed
36.
Zurück zum Zitat Tadimeti S. Rao, Jerry L, Currie, Shaffer Peter C, Isakson (1994) In vivo characterization of zymosan-Induced mouse peritoneal inflammation. J Pharmacol Exp Ther 269:917–925PubMed Tadimeti S. Rao, Jerry L, Currie, Shaffer Peter C, Isakson (1994) In vivo characterization of zymosan-Induced mouse peritoneal inflammation. J Pharmacol Exp Ther 269:917–925PubMed
37.
Zurück zum Zitat Issekutz AC, Issekutz TB (2002) The role of E-selectin, P-selectin, and very late activation antigen-4 in T lymphocyte migration to dermal inflammation. J Immunol 168:1934–1939PubMed Issekutz AC, Issekutz TB (2002) The role of E-selectin, P-selectin, and very late activation antigen-4 in T lymphocyte migration to dermal inflammation. J Immunol 168:1934–1939PubMed
38.
Zurück zum Zitat Wetheimer SJ, Myers CL, Wallace RW, Parks TP (1992) Intercellular adhesion molecule-1 gene expression in human endothelial cells. J Biol Chem 267:12030–12035PubMed Wetheimer SJ, Myers CL, Wallace RW, Parks TP (1992) Intercellular adhesion molecule-1 gene expression in human endothelial cells. J Biol Chem 267:12030–12035PubMed
Metadaten
Titel
Role of 5-lipoxygenase in the multiple organ failure induced by zymosan
verfasst von
Salvatore Cuzzocrea
Antonietta Rossi
Ivana Serraino
Rosanna Di Paola
Laura Dugo
Tiziana Genovese
Domenico Britti
Giuseppe Sciarra
Angelina De Sarro
Achille P. Caputi
Lidia Sautebin
Publikationsdatum
01.10.2004
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 10/2004
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-004-2353-y

Weitere Artikel der Ausgabe 10/2004

Intensive Care Medicine 10/2004 Zur Ausgabe

Announcements

October 2004

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.